如果企业客服不在线,也可拨打400电话联系。或者发布求购信息
MEK162(ARRY-162; ARRY-438162) is an oral, highly selective MEK inhibitor. MEK162(ARRY-162; ARRY-438162) is now being investigated in Phase I trials in advanced solid tumors.
Levitide
VU 0364439
T838219-250mg 替莫唑胺,puriss., >= 99.0 % HPLC
T820041-250mg 盐酸替罗非班,98%
L812676-5g 盐酸乐卡地平,≥98% (HPLC)
B803285-50mg 毕卡鲁胺,≥98% (HPLC), powder
C804978-25mg 磷酯酰乙醇胺,98%,氩气封装
AZD6482
A801403-2.5mg β 淀粉样蛋白片段1-40,≥95%(HPLC),powder
Rofecoxib